Related references
Note: Only part of the references are listed.Effects of Plasmodium falciparum parasite population size and patient age on early and late parasitological outcomes of antimalarial treatment in children
Steffen Borrmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Emergence of a dhfr mutation conferring high-level drug resistance in Plasmodium falciparum populations from southwest Uganda
Caroline Lynch et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Dihydrofolate reductase 1164L mutations in Plasmodium falciparum isolates:: clinical outcome of 14 Kenyan adults infected with parasites harbouring the 1164L mutation
Mary J. Hamel et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2008)
Antifolate resistance in Africa and the 164-dollar question
John E. Hyde
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2008)
Intermittent preventive therapy for malaria: progress and future directions
Martin P. Grobusch et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2007)
The safety of amodiaquine use in pregnant women
Harry K. Tagbor et al.
EXPERT OPINION ON DRUG SAFETY (2007)
The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics
Ishraga E. A-Elbasit et al.
MALARIA JOURNAL (2007)
Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy - A systematic review
Feiko O. ter Kuile et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Common origin and fixation of Plasmodium falciparum dhfr and dhps mutations associated with sulfadoxine-pyrimethamine resistance in a low-transmission area in South America
Andrea M. McCollum et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania
Mirjam Schoenfeld et al.
MALARIA JOURNAL (2007)
Safety and toxicity of sulfadoxine/pyrimethamine - Implications for malaria prevention in pregnancy using intermittent preventive treatment
Philip J. Peters et al.
DRUG SAFETY (2007)
Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria
Kasia Stepniewska et al.
MALARIA JOURNAL (2006)
Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania
Erasto V. Mbugi et al.
MALARIA JOURNAL (2006)
The effect of altitude on parasite density case definitions for malaria in northeastern Tanzania
Clare I. R. Chandler et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2006)
Antifolate resistance in Plasmodium falciparum:: Multiple origins and identification of novel dhfr alleles
Andrea M. McCollum et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Mutations associated with Sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi
AP Alker et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
A randomized, placebo-controlled, double-blind trial on sulfadoxine-pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malaria
FP Mockenhaupt et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2005)
Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response
S Krudsood et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2005)
Asymptomatic parasitaemia as a risk factor for symptomatic malaria in a cohort of Ugandan children
D Njama-Meya et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2004)
Relationship between age, molecular markers, and response to sulphadoxine-pyrimethamine treatment in Kampala, Uganda
SG Staedke et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2004)
Variation of malaria transmission and morbidity with altitude in Tanzania and with introduction of alphacypermethrin treated nets
CA Maxwell et al.
MALARIA JOURNAL (2003)
Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of plasmodium falciparum in three districts of northern Tanzania
RJ Pearce et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria
JG Kublin et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania
T Mutabingwa et al.
LANCET (2001)
Can pretreatment screening for dhps and dhfr point mutations in Plasmodium falciparum infections be used to predict sulfadoxine-pyrimethamine treatment failure?
SA Omar et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2001)
Share Paper
